DR REDDYS LABS ADR/1 IR 5
DR REDDYS LABS ADR/1 IR 5
Depository Receipt · US2561352038 · RDY · 659157 (XNYS)
Overview
15,54 USD
0,91 % 0,14 USD
NYSE (XNYS) · Current prices and charts at MoneyPeak
06.06.2025 19:59

Current Prices from DR REDDYS LABS ADR/1 IR 5

ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
RDY
USD
06.06.2025 19:59
15,54 USD
15,53 USD
+0,06 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 5,64 % 15,15 % 19,63 % 6,58 % 10,45 % -70,70 %

Company Profile for DR REDDYS LABS ADR/1 IR 5 Depository Receipt

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Company Data

Name DR REDDYS LABS ADR/1 IR 5
Company Dr. Reddy's Laboratories Limited
Symbol RDY
Website https://www.drreddys.com
Primary Exchange XNYS NYSE
WKN 659157
ISIN US2561352038
Asset Class Depository Receipt
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Erez Israeli M.B.A.
Market Capitalization 11 Mrd.
Country India
Currency USD
Employees 27,0 T
Address 8-2-337, Road No. 3, 500034 Hyderabad
IPO Date 2001-04-11

Stock Splits

Date Split
05.11.2024 5:1
07.09.2006 2:1

Ticker Symbols

Name Symbol
Frankfurt RDDA.F
NYSE RDY

More Shares

Investors who DR REDDYS LABS ADR/1 IR 5 hold also have the following shares in their portfolio:
AGNICO EAGLE MINES LTD
AGNICO EAGLE MINES LTD Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
ASML HOLDING
ASML HOLDING Share
CREDIT AGR.LDN 17/22 MTN
CREDIT AGR.LDN 17/22 MTN Bond
HUGO BOSS
HUGO BOSS Share
ISIV-NASDAQ US BIOTE. DLA
ISIV-NASDAQ US BIOTE. DLA ETF
KRED.F.WIED.25/35 MTN
KRED.F.WIED.25/35 MTN Bond
MINERAL RES LTD
MINERAL RES LTD Share
NETFLIX INC
NETFLIX INC Share
NIKE INC - CLASS B
NIKE INC - CLASS B Share
NVIDIA CORP
NVIDIA CORP Share
SHOPIFY A SUB.VTG
SHOPIFY A SUB.VTG Share
SYMRISE AG
SYMRISE AG Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025